copenlu/druid huggingface dataset:
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2024-09-12): - The mRNA COVID-19 vaccines present a risk of subclinical and clinical myocarditis and other cardiovascular conditions among otherwise healthy individuals. - The mRNA COVID-19 vaccine may be associated with an increased risk of postural orthostatic tachycardia syndrome (POTS). [...] - Potential DNA integration from the mRNA COVID-19 vaccines pose unique and elevated risk to human health and to the integrity of the human genome, including the risk that DNA integrated into sperm or egg gametes could be passed onto offspring of mRNA COVID-19 vaccine recipients.
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2024-09-27): Getting vaccinated builds protection against COVID-19, protecting people from the potentially serious consequences of getting the disease, including hospitalization and death. [...] There is a rare risk of inflammation of the heart or its surrounding tissue (myocarditis or pericarditis) after COVID-19 vaccines, often in adolescent and young adult males. However, importantly, in one study, the risk of cardiac complications in males 12-17 years old was 1.8 – 5.6 times higher after getting COVID-19 disease than after receiving an mRNA COVID-19 vaccine. Most people who were reported to have myocarditis after mRNA COVID-19 vaccination responded well to medicine and rest and had resolution of symptoms by the time they went home from the hospital. A study found that most patients with myocarditis after mRNA COVID-19 vaccination were considered to have recovered by their healthcare provider after at least 90 days since onset.
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2024-02-08): Claim that myocarditis from COVID-19 vaccines carries serious risk of death is based on flawed study [...] It cited the study’s conclusion stating that "COVID-19 vaccination is strongly associated with a serious adverse safety signal of myocarditis, particularly in children and young adults resulting in hospitalization and death". [...] Multiple published studies have shown that the clinical course of COVID-19 vaccine-induced myocarditis is mild for the majority, and contrary to the claims by Rose et al. and The Blaze, don’t entail serious risks of hospitalization and death. Studies have also shown that it is COVID-19—not COVID-19 vaccines—that is associated with a greater risk of cardiovascular diseases and other complications. Reliable scientific studies show that the benefits of COVID-19 vaccination outweigh the risks.
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2024-09-27): The COVID-19 vaccine is very effective at preventing serious illness, hospitalization and death. Because the virus that causes COVID-19 continues to change, vaccines are updated periodically to help fight the disease. It is important to check the Centers for Disease Control and Prevention (CDC) COVID-19 vaccine information website for the latest details. [...] People who are pregnant or were recently pregnant are at a greater risk for severe COVID-19. Having a severe case of COVID-19 while pregnant is linked to a higher risk of preterm birth and stillbirth and might increase the risk of other pregnancy complications. For these reasons, COVID-19 vaccination is recommended for people who are pregnant, intending to become pregnant or were recently pregnant. [...] Yes. COVID-19 vaccines approved by the FDA meet rigorous testing criteria and are safe and effective at preventing serious illness, hospitalization and death. Millions of people have received the vaccines, and the CDC continues to monitor their safety and effectiveness as well as rare adverse events.
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2023-08-18): According to the CDC, age remains the strongest predictor of poor outcomes and severe illness in patients with COVID-19. Data from the National Vital Statistics System (NVSS) at CDC states that patients with COVID-19 aged 50 to 64 years have a 25 times higher risk of death when compared to adults infected with this illness and aged less than 30 years. In patients 65 to 74 years old, this risk increases to 60 times. In patients older than 85, the risk of death increases to 340 times. According to the CDC, these data include all deaths in the United States throughout the pandemic, from February 2020 to July 1, 2022, including deaths among unvaccinated individuals. [...] Cardiac involvement in COVID-19 is common and likely multifactorial. ACE2 receptors exhibited by myocardial cells may cause direct cytotoxicity to the myocardium leading to myocarditis. Proinflammatory cytokines such as IL-6 can also lead to vascular inflammation, myocarditis, and cardiac arrhythmias.[56] [...] Myocardial injury manifesting as myocardial ischemia/infarction (MI) and myocarditis are well-recognized cardiac manifestations in patients with COVID-19. Single-center retrospective study analysis of 187 patients with confirmed COVID-19 reported that 27.8% of patients exhibited myocardial injury indicated by elevated troponin levels. The study also noted that patients with elevated troponin levels had more frequent malignant arrhythmias and a higher mechanical ventilation frequency than patients with normal troponin levels.[71] A meta-analysis of 198 published studies involving 159698 COVID-19 patients reported that acute myocardial injury and a high burden of pre-existing cardiovascular disease were significantly associated with higher mortality and ICU admission.[72]
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2023-03-08): The MHRA has undertaken a thorough review of both UK and international reports of suspected myocarditis and pericarditis following vaccination against COVID-19. There has been a consistent pattern of higher reporting of these suspected events with both the monovalent COVID-19 Vaccine Pfizer/BioNTech and COVID-19 Vaccine Moderna, and of these occurring more frequently in males. These reports have also been analysed by the government’s independent advisory body, the CHM and its COVID-19 Vaccines Benefit Risk Expert Working Group. Following their advice, the product information for both monovalent COVID-19 Vaccine Moderna and COVID-19 Vaccine Pfizer/BioNTech was updated to inform healthcare professionals and patients of these reports and provide advice to be aware of important symptoms for myocarditis and pericarditis. This advice has also been included in the product information for the bivalent (original/Omicron BA.1) COVID-19 vaccines for Moderna and Pfizer/BioNTech.
Claim: Study shows myocarditis from COVID-19 vaccination carries serious risk of death (Joseph Mackinnon, 2024-01-29)
Evidence (2022-05-17): The widespread use of COVID-19 vaccines, including in the elderly and in patients with underlying health conditions, means that there have been deaths and serious illnesses that are purely coincidental and unrelated to vaccinations. The job of each regulator, often supported by independent committees of relevant medical experts together with vaccine manufacturers, is to review the cases and determine if there are potential safety signals with the vaccines. There is a special focus on monitoring safety in some groups of people that may not have been included in clinical trials or included as a small number, such as pregnant women, persons with severe pre-existing illness, older people, children, and in people also receiving vaccines for prevention of other diseases. [...] Myocarditis has most often been reported after the second dose in 12 to 17 year old boys and men under 30. Several countries have observed higher reporting rates of myocarditis with those vaccinated with the Moderna COVID-19 vaccine than the Pfizer vaccine, but the reported difference in rates has differed between studies and countries may be influenced by a variety of factors. The benefit-risk of both of the vaccines remains positive. Pericarditis following a mRNA vaccine tends to occur at an older median age than myocarditis, but it is nonetheless more common in people under 50 years of age than in older people.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2015-11-08): While VAERS maintains a record of adverse events reported after vaccination, no causal relationship between HPV vaccines and any of the serious side effects reported has been identified in scientific studies. In the US, approximately 13,000 new cases of cervical cancer will be diagnosed every year, and in 2016, more than 200,000 women were living with the disease. HPV vaccines play an important role in protecting future generations of women from cervical cancer.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2021-02-08): For the four vaccines listed above, common side effects include - pain at the site of the injection - painful, swollen lymph nodes in the arm where the vaccine was injected - tiredness - headache - muscle or joint aches - nausea and vomiting - fever or chills.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2024-09-18): The HPV vaccine reduces your chances of getting human papillomavirus (HPV), a common virus that's spread through skin contact (usually when having sex). [...] The most common side effects of the HPV vaccine are mild and do not last long. [...] More serious side effects such as a severe allergic reaction are very rare. The person who vaccinates you will be trained to deal with allergic reactions and treat them immediately.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2024-10-08): The importance of the HPV vaccine from a standpoint of oral health is that it protects against cancers that result from HPV infection, including oropharyngeal cancers. Approximately 80% of oropharyngeal cancers are associated with HPV and could potentially be prevented with the vaccine. It should be emphasized that it is intended as a preventive measure and it is not intended as a treatment. [...] Clinical trials have demonstrated the safety of the HPV vaccines. The most common adverse effects are mild-moderate injection site reactions, with some patients reporting systemic adverse effects including headache, fever, nausea, or dizziness. Large studies have not supported anecdotal reports raising concern for multiple sclerosis and other demyelinating disorders. [...] But of note: For those patients who have oropharyngeal cancers that are HPV-positive, but who also have the risk factors of cigarette smoking or heavy alcohol consumption, this seems to negate a positive relationship outcome. For reasons we may not fully understand, the risk factors of smoking and drinking seem to outweigh the HPV factor in terms of determining prognosis.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2024-02-29): Many popular posts on social media have shared results from the study, some lacking the context that the identified health problems are rare, that most aren’t new and that the vaccines have proven benefits. Various posts made unfounded claims, stating or implying that people should not have received the vaccines, that the risks outweigh the benefits or that the risk of the rare side effects is greater than was reported in the study. [...] Identifying those at greater risk of side effects can help guide decisions on which vaccines to recommend and what problems doctors should watch for in their patients. [...] Liberty Counsel (@libertycounsel). "… "Based on ‘conservative assumptions,’ the estimated harms of the COVID-19 mRNA vaccines ‘greatly outweigh the rewards,’ the article stated, noting that ‘for every life saved, there were nearly 14 times more deaths caused by the modified mRNA injections.’" …" Instagram. 20 Feb 2024.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2021-04-23): The benefits of Vaxzevria outweigh its risks in adults of all age groups; however, very rare cases of blood clots with low blood platelets1 have occurred following vaccination.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2024-08-10): - Redness, warmth, and swelling where the shot is given and fever can happen after Hib vaccination. [...] HPV-Gardasil-9 vaccine side effects (human papillomavirus Gardasil-9 vaccine) [...] - Fever or headache can happen after HPV vaccination.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2021-03-31): Mild-to-moderate side effects, like a low-grade fever or muscle aches, are normal and not a cause for alarm: they are signs that the body’s immune system is responding to the vaccine, specifically the antigen (a substance that triggers an immune response), and is gearing up to fight the virus. These side effects usually go away on their own after a few days. Common and mild or moderate side effects are a good thing: they show us that the vaccine is working. Experiencing no side effects doesn’t mean the vaccine is ineffective. It means everybody responds differently.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2022-05-06): HPV vaccines are very safe. Scientific research shows the benefits of HPV vaccination far outweigh the potential risks. Like all medical interventions, vaccines can have some side effects. More than 135 million doses of HPV vaccine have been distributed in the United States since the vaccine was introduced in 2006. The most common side effects associated with HPV vaccines are mild and include pain, redness, or swelling in the arm where the shot was given. [...] The HPV vaccine works extremely well. In the 10 years after the vaccine was recommended in 2006 in the United States, quadrivalent type HPV infections decreased by 86% in female teens aged 14 to 19 years and 71% in women in their early 20s. Research has also shown that fewer teens and young adults are getting genital warts and that cervical precancers are decreasing since HPV vaccines have been in use in the United States. Decreases in vaccine-type prevalence, genital warts, and cervical precancers have also been observed in other countries with HPV vaccination programs.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2018-10-24): The HPV vaccine has already shown promise in helping to stem long-rising rates of cancers transmitted by the virus, including an estimated 31,500 cases in the United States annually of cancers of the cervix, vagina, vulva, oropharynx and anus. The U.S. Food and Drug Administration approved the vaccine—beginning at age 9—in 2006 for females and in 2009 for males. But it wasn’t recommended for use in males until 2011 by the Advisory Committee on Immunization Practices, the group of medical experts that gives guidance on vaccines for the public. Worldwide studies have shown the vaccine to be virtually 100 percent effective and very safe, with the FDA concluding that the vast majority of side effects are minor, and that benefits continue to outweigh adverse events. [...] Beavis says that their findings demonstrate that parents are less concerned with the HPV vaccine’s relation to gender and sexual activity, and that public health campaigns should focus on persistent concerns about safety and necessity of the vaccine for both boys and girls in order to be responsive to parents’ true concerns. She suggests that doctors who commonly administer the HPV vaccine, including family practice physicians, obstetricians/gynecologists and pediatricians, should focus on the fact that the HPV vaccine has enormous potential to prevent cancers and has a strong safety profile from over a decade of vaccine administration. [...] The HPV vaccine can protect against nine cancer-causing strains of HPV. The recommended dosing schedule for the vaccine now involves two injections if the first is administered before age 15, or three injections if the first is administered after age 15.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2023-01-20): Side effects from the polysaccharide version used mostly in adults include tenderness and redness at the injection site, and about 1 of every 100 people will get a fever and experience muscle aches. [...] Pneumococcal bacteria still cause hundreds of cases of meningitis, bloodstream infections and pneumonia every year in the United States. Because the pneumococcal vaccine does not cause serious side effects, the benefits of the vaccine clearly outweigh its risks.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2024-04-16): Yes, the HPV vaccine is safe for almost everyone. No serious negative effects have resulted from the vaccine, except for allergic reactions and fainting, which can happen after any vaccination. [...] Most people, especially young people, should get the HPV vaccination. The benefits of the shot vastly outweigh the few risks. The HPV vaccine can prevent up to The side effects of the HPV vaccine are minor. The only known risk that can become serious is anaphylaxis, which is
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2024-01-01): Like any vaccine or medicine, HPV vaccines can cause side effects. The most common side effects are pain, redness or swelling in the arm where the shot was given, dizziness, fainting, nausea and headache. HPV vaccination does not usually cause serious side effects. The benefits of HPV vaccination far outweigh any poossible risk of side effects. [...] Reports of blood clots, strokes, heart attacks, chronic fatigue syndrome, infertility or premature ovarian failure, and even death have occurred after receipt of this vaccine; however, studies of people who did and did not get the vaccine have shown that none of these problems were caused by the HPV vaccine. [...] No. There is no information that suggests the HPV vaccine will cause problems with the ability to get pregnant. In fact, getting vaccinated and protecting against cervical cancer can help women have healthy pregnancies and have healthy babies. Not getting the HPV vaccine leaves people without protection to HPV infection; for women, this could lead to cervical cancer. The treatment of cervical cancer (hysterectomy, chemotherapy, and/or radiation, for example) could leave a woman unable to have children. Even the treatment of cervical pre-cancers caused by HPV can cause preterm labor or problems at the time of delivery.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2022-05-17): After a vaccine is approved for use, regulators conduct robust effectiveness monitoring as well as monitoring of safety and risk minimisation activities (pharmacovigilance). They need to continuously monitor vaccine safety to ensure that the benefits of the vaccine continue to outweigh the risks. Regulators do this by: [...] Regulators, often in collaboration with public health authorities, can take decisive action if a safety issue is identified. These actions can include issuing safety communications for patients, healthcare professionals and the community; updating the product information or consumer information for the vaccine; preventing the release of a particular batch of vaccine; and, taking other regulatory actions such as restriction of vaccine authorisation to a particular subgroup of the community or revocation of authorisation. Regulators approve and maintain an approval of a vaccine only if they determine that the known and potential benefits of the vaccine outweigh its known and potential risks.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2016-04-08): Although vaccines undoubtedly reduce the incidence of several infectious diseases, which strongly supports that the benefits outweigh the risks, side effects still need to be closely monitored and reported without bias. For HPV vaccines, the body of evidence suggests that their potential to elicit life-threatening side effects is very low with autoimmune responses being the greatest concern. While the reduction in the occurrence of genital warts conferred by the HPV types present in the vaccines strongly suggests an ultimately lower incidence of HPV-positive cancers, the time period since the initial vaccinations has not been sufficient to determine the absolute reduction in cervical cancer, the major benefit expected. For this reason, it is important to stress the need to maintain routine surveillance for lower genital tract diseases especially in women, even if there is widespread use of the HPV vaccine.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2023-05-22): Although HPV vaccines have not been linked to causing adverse pregnancy outcomes or side effects (adverse events) to the developing fetus among pregnant people vaccinated inadvertently, HPV vaccines have not been studied in pregnant people in clinical trials. [...] HPV vaccines are very safe. Scientific research shows the benefits of HPV vaccination far outweigh the potential risks. Like all medical interventions, vaccines can have some side effects. [...] Adverse Reactions - The most common adverse reactions reported during clinical trials of HPV vaccines were local reactions at the site of injection.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2020-01-08): New data collected by the Pew Research Center show that 88% of Americans believe the health benefits of measles, mumps, and rubella (MMR) vaccination outweigh the risks, but there were significant differences among race, age, and education level—and a separate study highlights the impact of misinformation surrounding the human papillomavirus (HPV) vaccine.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2020-01-02): The science is in. The benefits of vaccines far outweigh the risks. Still, the debate about the value of vaccines continues. Here are some facts from Kaiser Permanente Washington Health Research Institute to help you make the right health decision for your child. [...] Some strains of HPV are linked to certain cancers. The HPV vaccine helps protect against those virus strains.
Claim: side effects of the [HPV] vaccine outweigh the positives (Anonymous, 2015-11-08)
Evidence (2021-10-22): Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a new study has found that more parents are citing concerns about the vaccines’ safety in recent years. The findings highlight an urgent need for doctors and public health leaders to address these concerns with parents, according to the scientists who led the study. The HPV vaccine protects against six different kinds of cancer (cervical, anal, back of the throat, penile, vaginal, and vulvar) that are caused by infection with the human papillomavirus, or HPV. [...] HPV vaccines can cause pain, swelling, and redness where the shot was given, as well as headaches, tiredness, and nausea. The most common serious side effects of HPV vaccination are dizziness and fainting. There is no evidence that HPV vaccines lead to infertility or autoimmune diseases, although these are common myths.